Official registry condition

Hepatic Impairment peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Hepatic Impairment. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

3 profiles.

Registry update years

2021–2025 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases1

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hepatic Impairment unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT05706623

PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
July 10, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06052566

PeptideScanner retained ClinicalTrials.gov record NCT06052566 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-10-22, and PeptideScanner's reviewed identity mapping was efinopegdutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 22, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00819468

PeptideScanner retained ClinicalTrials.gov record NCT00819468 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2021
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →